A trader invested in LABUBU eight months ago and now has a floating profit of $1.26 million, while LUCE has turned from profit to loss
According to Lookonchain monitoring, a whale address "DBzhEX" spent $72,200 eight months ago to purchase 30.94 million LABUBU tokens, which are now valued at $1.26 million, achieving a substantial unrealized gain. However, this address spent $527,000 seven months ago to buy 19.14 million LUCE tokens, an investment that once surged to $5.74 million but has now dropped to only $164,000, turning a $5.2 million unrealized gain into a $363,000 loss.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Why Is SpaceX Stock Price Down Today?
Strong demand for Wegovy oral tablets drives Novo Nordisk (NVO.US) Q3 revenue and profit to surpass expectations, with annual performance guidance raised again.
Novo Nordisk released its financial report for the first three quarters of 2026 on November 4.
JPMorgan maintains “Overweight” rating on Unilever (UL.US): The new mid-term framework strengthens growth quality, and high single-digit EPS growth is expected to drive revaluation.
JPMorgan released a research report, maintaining an "Overweight" rating for Unilever and setting its European stock target price at 65 euros and its UK stock target price at 5,700 pence.
Hemnet Appoints Michael Hansen as Interim CEO
